Logo Image

Authors

Michael Blackman, MD
Latest Article

Patient Experiences Can Affect a Practice’s Financial Health

The patient experience is a critical factor in the success of any healthcare practice, and its importance is increasing with the rise of health care consumerism.

Sponsored by Janssen Oncology
Latest Article

Bispecific Targeting CD3 and BCMA Reflect Expanding Options in Multiple Myeloma

Bispecific antibodies targeting BCMA have shown efficacy in relapsed refractory multiple myeloma, including bispecifics targeting BCMA x CD3.

Vincent Ma, MD
Vincent Ma, MD

Vincent Ma, MD, is an assistant professor and a faculty member in the Division of Hematology, Medical Oncology and Palliative Care within the Department of Medicine at the University of Wisconsin School of Medicine and Public Health in Madison.

Latest Article

Percutaneous Hepatic Perfusion Could Boost Immunotherapy Response in Metastatic Melanoma

Disrupting liver-driven immune sink by depleting macrophages and preventing T-cell clearance restores responsiveness to immunotherapy in melanoma.

Ronda S. Henry-Tillman, MD
Latest Article

Comprehensive Treatment Advances Care for Patients With Early-Stage Breast Cancer

Advances in the diagnosis and treatment of early-stage breast cancer highlight the need for clinicians to adapt to paradigm shifts that will have notable effects on patient care.

Toby Campbell, MD, MSCI
Latest Article

Palliative Care Builds Bridges in Oncology Practice

Toby Campbell, MD, MSCI, discusses the nuances of palliative care in oncology.

Sarah Wolfson, PhD
Latest Article

The Microbiome and Colon Cancer: Dietary Influence on Incidence, Morbidity, and Mortality

One of the prime risk factors for CRC is the consumption of a high-risk, Western-style diet high in processed foods, refined grains, red meat, and sugar.

Chunhui Fang, MD
Michelle Shiller, MD
Judy Schreiber, PhD, RN
Latest Article

Cemiplimab monotherapy for first-line advanced NSCLC patients with PD-L1 expression ≥50%: 6-y outcomes of EMPOWER-Lung 1

Rapid readout: Real-world lifileucel TIL shows 44% responses in metastatic melanoma, favoring early referral and manageable IL-2 toxicity.

Reena V. Jayani, MD
Latest Article

Evidence Supports Value of Physical Activity in Patients With Cancer

Baseline physical activity and physical function prior to a cancer diagnosis or treatment affects survival, with evidence spanning across solid tumor types and hematologic malignancies.

Sid Devarakonda, MBBS, MD
Latest Article

Ongoing Research to Watch in EGFR-Mutated NSCLC

Natalie Vokes, MD, and Sid Devarakonda, MBBS, MD, discuss ongoing research shaping EGFR-mutated NSCLC care.

Siddhartha Yadav, MBBS, MD
Justin Mancini
Latest Article

RSK Inhibition Is Poised for Deeper Activity in RSK-High, CDK4/6 Inhibitor–Resistant Breast Cancer

PMD-026 inhibits RSK to block tumor growth signals and ER activity, a potential strategy to overcome CDK4/6 inhibitor resistance in breast cancer.

Katelyn Handley, MD
Matthew Schwede, MD
Latest Article

Building Upon Scaffolds

Cancer care is changing rapidly, and understanding and incorporating new practices is challenging both for practicing oncologists and oncology trainees.

Moffitt Cancer Center
Latest Article

How Genetic Information Keeps Cells Alive: A New Model from Moffitt Cancer Center

A new model explains how genetic information is not just stored but continuously used to keep cells organized and functioning.

Oleg Bess, MD
Latest Article

Data Quality Issues Plague the US Health Care System

Oleg Bess, MD, explains why data quality is essential to improving the United States health care system.

Cheney Gazzam Baltz
Latest Article

Prevention and Personalization Drive the Future of Oncodermatology in Melanoma

Beth N. McLellan, MD, discusses radiation dermatitis prevention, scalp cooling equity, and the future of personalized oncodermatology in melanoma management.

AdventHealth Cancer Institute
Latest Article

Novel Detection Methods May End Chemotherapy for Patients With CRC

A new genetic test that may allow patients with colorectal cancer to avoid chemotherapy after tumor resection is under investigation at AdventHealth Cancer Institute in Orlando, Florida.

The Ohio State University Comprehensive Cancer Center
Latest Article

Ohio State Recruits Top Oncologist to Expand Cell Therapy Program, Lead Bone Marrow Transplant Services

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute has recruited Marcos J. de Lima, MD, to lead its Blood and Marrow Transplant and Cellular Therapy programs, two key leadership positions within central Ohio’s only National Cancer Institute-designated comprehensive cancer center and largest freestanding hospital.

Melinda Krigel
Latest Article

UCSF Prostate Cancer Program Awarded SPORE Grant by National Cancer Institute

Researchers will investigate aggressive prostate cancer from a mechanistic, biomarker and therapeutic perspective.

Nikhil Wagle, MD
Latest Article

Direct Partnership With Patients May Accelerate Cancer Research and Precision Oncology

During the past several decades, cancer research has produced revolutionary discoveries leading to dramatic results for many patients.

Lilyana Angelov, MD
Latest Article

Clinical Updates for the Management of Lung Cancer Brain Metastases

As improved cancer therapies are helping patients live longer, the safe and effective management of lung cancer brain metastases is coming to the fore.

Lisa Langenderfer
Latest Article

Physicians Must Become Advocates to Play a Role in Community Oncology’s Future

Although some community oncologists may think they can do little to abate the reimbursement reform forces that are affecting their practices, there are actions they can, and should, take to influence the success of their value-based care journey that may not be part of the fundamentals of their current practice.

Giuseppe Procopio, M.D., Head of the Genitourinary Unit at Fondazione Istituto Nazionale Tumori, Milan, Italy
Latest Article

Multi-stakeholder collaboration: the catalyst for innovation in kidney cancer care

Sponsored Content by Ipsen

Dana-Farber Cancer Institute
Latest Article

Massachusetts Public Health Alliance’s 2026 Lemuel Shattuck Award presented to Dana-Farber’s Magnolia Contreras

Magnolia Contreras, MSW, MBA, of Dana-Farber Cancer Institute, was honored with The Lemuel Shattuck Award for Significant Contributions to Public Health Practice.

Hannah Clarke
Latest Article

Gemcitabine Intravesical System Yields Low Rate of Radical Cystectomy in BCG-Unresponsive, High-Risk NMIBC

Gemcitabine intravesical system in BCG-unresponsive, high-risk NMIBC led to high CR rates and low radical cystectomy rates.

Ashley L. Greenwood, MD
Latest Article

Why Oncologists Should Know More About Medical Marijuana

Increasingly, patients are asking oncologists for guidance and recommendations for the use of medical marijuana. However, finding those answers is challenging because of the federal government.

Bruce D. Rapkin, PhD
Latest Article

Now is the Time to Improve Diversity in Cancer Clinical Trial

Fewer African American and Hispanic patients participated in oncology trials from 2003 to 2016 than from 1996 to 2002.

Sponsored Content by AbbVie Inc. and Genentech USA, Inc.